Chan SYT - Search Results

1

SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis.

Abdel-Fatah TMA, Agarwal D, Liu DX, Russell R, Rueda OM, Liu K, Xu B, Moseley PM, Green AR, Pockley AG, Rees RC, Caldas C, Ellis IO, Ball GR, Chan SYT. Abdel-Fatah TMA, et al. Among authors: chan syt. Lancet Oncol. 2016 Jul;17(7):1004-1018. doi: 10.1016/S1470-2045(16)00174-1. Epub 2016 Jun 14. Lancet Oncol. 2016. PMID: 27312051 Clinical Trial.

2

Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?

Dixon AR, Jackson L, Chan SY, Badley RA, Blamey RW. Dixon AR, et al. Br J Cancer. 1993 Jul;68(1):181-5. doi: 10.1038/bjc.1993.310. Br J Cancer. 1993. PMID: 8318411 Free PMC article. Clinical Trial.

3

C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer.

Willsher PC, Pinder SE, Gee JM, Ellis IO, Chan SY, Nicholson RI, Blamey RW, Robertson JF. Willsher PC, et al. Anticancer Res. 1998 Sep-Oct;18(5B):3695-8. Anticancer Res. 1998. PMID: 9854479

4

Second-line chemotherapy for ovarian cancer.

Chan S. Chan S. Lancet Oncol. 2003 Jun;4(6):333-4. doi: 10.1016/s1470-2045(03)01087-8. Lancet Oncol. 2003. PMID: 12788402 No abstract available.

5

Metastatic carcinoma of the breast with tubular features: differences compared with metastatic ductal carcinoma of no specific type.

Hamilton LJ, Evans AJ, Pinder SE, James JJ, Gutteridge E, Cornford EJ, Burrell HC, Chan SY, Robertson JF, Cheung KL. Hamilton LJ, et al. Clin Oncol (R Coll Radiol). 2004 Apr;16(2):119-24. doi: 10.1016/j.clon.2003.11.007. Clin Oncol (R Coll Radiol). 2004. PMID: 15074735

6

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.

Panigrahi AR, Pinder SE, Chan SY, Paish EC, Robertson JF, Ellis IO. Panigrahi AR, et al. J Pathol. 2004 Sep;204(1):93-100. doi: 10.1002/path.1611. J Pathol. 2004. PMID: 15307142

7

Brain metastases from breast cancer: identification of a high-risk group.

Evans AJ, James JJ, Cornford EJ, Chan SY, Burrell HC, Pinder SE, Gutteridge E, Robertson JF, Hornbuckle J, Cheung KL. Evans AJ, et al. Clin Oncol (R Coll Radiol). 2004 Aug;16(5):345-9. doi: 10.1016/j.clon.2004.03.012. Clin Oncol (R Coll Radiol). 2004. PMID: 15341438

8

Modern chemotherapy management of recurrent ovarian cancer: a multicentre study.

Chan S, Griffin M, Stewart J, Gregory K, Hughes A, Awwad S, Allerton R, Pledge S, Thomas H, Percival F; Ovarian Cancer Audit Group UK. Chan S, et al. Clin Oncol (R Coll Radiol). 2007 Mar;19(2):129-34. doi: 10.1016/j.clon.2006.10.002. Clin Oncol (R Coll Radiol). 2007. PMID: 17355109

9

Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.

Mathew J, Asgeirsson KS, Agrawal A, Mukherjee A, Ellis IO, Cheung KL, Chan SY, Robertson JF. Mathew J, et al. Eur J Surg Oncol. 2007 Oct;33(8):972-6. doi: 10.1016/j.ejso.2007.02.005. Epub 2007 Mar 27. Eur J Surg Oncol. 2007. PMID: 17391905 Clinical Trial.

10

Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions.

Mathew J, Asgeirsson KS, Cheung KL, Chan S, Dahda A, Robertson JF. Mathew J, et al. Eur J Surg Oncol. 2009 Feb;35(2):113-22. doi: 10.1016/j.ejso.2008.03.015. Epub 2008 May 23. Eur J Surg Oncol. 2009. PMID: 18502088 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page